Home/Filings/8-K/0001274737-26-000003
8-K//Current report

EXAGEN INC. 8-K

Accession 0001274737-26-000003

$XGNCIK 0001274737operating

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 9:03 AM ET

Size

175.5 KB

Accession

0001274737-26-000003

Research Summary

AI-generated summary of this filing

Updated

Exagen Inc. Announces Preliminary Q4 and Full-Year 2025 Financial Results

What Happened
Exagen Inc. (XGN) announced on January 11, 2026 (via a press release furnished as Exhibit 99.1 to the 8‑K) select preliminary unaudited financial information and results of operations for the three months and year ended December 31, 2025. The company noted its financial closing procedures are not complete and that these procedures often produce changes to accounts, so the final audited results may differ from the preliminary figures. BDO USA, P.C. has not audited, reviewed, compiled, or applied agreed‑upon procedures to the preliminary information and therefore expresses no assurance on it.

Key Details

  • Announcement date: January 11, 2026 (press release furnished as Exhibit 99.1).
  • Period covered: three months and year ended December 31, 2025 (select preliminary unaudited results).
  • Financial close: closing procedures remain incomplete; preliminary results may change when final statements are issued.
  • Audit status: BDO did not audit or review the preliminary figures and provided no opinion or assurance.

Why It Matters
Preliminary earnings disclosures can move investor expectations and share prices, but these figures are unaudited and subject to revision during final close and audit processes. Retail investors should treat the reported preliminary results as provisional and await the company’s finalized, audited financial statements before drawing firm conclusions about revenue, profitability, or trend changes. The press release has been deemed filed for regulatory purposes, making the disclosed information officially part of Exagen’s public filings.